- Home
- DGX vs XPEV Comparison
DGX vs XPEV Comparison
Compare DGX & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGX
- XPEV
- Stock Information
- Founded
- DGX 1967
- XPEV 2015
- Country
- DGX United States
- XPEV China
- Employees
- DGX N/A
- XPEV N/A
- Industry
- DGX Medical Specialities
- XPEV Auto Manufacturing
- Sector
- DGX Health Care
- XPEV Consumer Discretionary
- Exchange
- DGX Nasdaq
- XPEV Nasdaq
- Market Cap
- DGX 20.5B
- XPEV 21.7B
- IPO Year
- DGX 1996
- XPEV 2020
- Fundamental
- Price
- DGX $176.05
- XPEV $22.96
- Analyst Decision
- DGX Buy
- XPEV Buy
- Analyst Count
- DGX 15
- XPEV 8
- Target Price
- DGX $194.07
- XPEV $22.51
- AVG Volume (30 Days)
- DGX 1.1M
- XPEV 7.0M
- Earning Date
- DGX 10-21-2025
- XPEV 11-18-2025
- Dividend Yield
- DGX 1.79%
- XPEV N/A
- EPS Growth
- DGX 14.49
- XPEV N/A
- EPS
- DGX 8.51
- XPEV N/A
- Revenue
- DGX $10,850,000,000.00
- XPEV $8,416,181,216.00
- Revenue This Year
- DGX $11.17
- XPEV $99.32
- Revenue Next Year
- DGX $3.48
- XPEV $39.73
- P/E Ratio
- DGX $20.53
- XPEV N/A
- Revenue Growth
- DGX 13.74
- XPEV 66.37
- 52 Week Low
- DGX $148.70
- XPEV $10.92
- 52 Week High
- DGX $197.55
- XPEV $27.16
- Technical
- Relative Strength Index (RSI)
- DGX 38.37
- XPEV 57.10
- Support Level
- DGX $174.70
- XPEV $20.95
- Resistance Level
- DGX $184.73
- XPEV $23.75
- Average True Range (ATR)
- DGX 4.08
- XPEV 0.65
- MACD
- DGX -1.22
- XPEV 0.12
- Stochastic Oscillator
- DGX 5.91
- XPEV 73.88
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 190,000 EVs in 2024, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.